Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract Paul B. Kluger, MD, and colleagues, Lahey Clinic, Burlington, Mass, reported using the neodymium-YAG laser in treating a group of 19 patients with hereditary hemorrhagic telangiectasia. Sufficient data were obtained to analyze results in 17 of 19 patients with a follow-up of two months to 3.5 years. Laser power was 20 to 30 W, with exposure settings of 0.2 to 0.5 s. A flexible unfocused quartz fiber inserted through a malleable suction tip was used with the operating microscope for treatment. With the fibertip held approximately 2 cm from the telangiectasias, laser energy was first applied circumferentially around the telangiectasia before direct photocoagulation of each lesion. Local anesthesia with intravenous sedation was used in two thirds of the treatment sessions and standard general anesthesia in the remainder. Postoperative nasal packing was not necessary in most patients, and absorbable hemostatic agents were used when packing was required. Patients with no history
Archives of Otolaryngology - Head & Neck Surgery – American Medical Association
Published: Aug 1, 1987
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.